Mingxia Song

474 total citations
15 papers, 385 citations indexed

About

Mingxia Song is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mingxia Song has authored 15 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Mingxia Song's work include Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (7 papers) and vaccines and immunoinformatics approaches (5 papers). Mingxia Song is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (7 papers) and vaccines and immunoinformatics approaches (5 papers). Mingxia Song collaborates with scholars based in Germany, United States and Switzerland. Mingxia Song's co-authors include Dirk Schadendorf, Annette Paschen, Yuansheng Sun, Stefan Stevanović, Antje Sucker, Francisco Ruiz‐Cabello, Federico Garrido, Pilar Jiménez, Rosa Méndez and Katharina Janek and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Mingxia Song

15 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxia Song Germany 8 254 188 167 52 23 15 385
Jane Humphreys United Kingdom 8 127 0.5× 213 1.1× 133 0.8× 173 3.3× 20 0.9× 10 402
Marina Castellano Australia 7 154 0.6× 165 0.9× 198 1.2× 10 0.2× 47 2.0× 7 399
Nicolas Acquavella United States 8 229 0.9× 238 1.3× 133 0.8× 11 0.2× 7 0.3× 11 383
Christian Aubert France 7 250 1.0× 90 0.5× 100 0.6× 20 0.4× 33 1.4× 12 372
K. Montone United States 6 168 0.7× 167 0.9× 106 0.6× 9 0.2× 26 1.1× 11 331
Satoko Inoda Japan 11 187 0.7× 330 1.8× 296 1.8× 12 0.2× 43 1.9× 12 552
Seth Wardell United States 5 82 0.3× 88 0.5× 71 0.4× 74 1.4× 15 0.7× 5 194
Hömig-Hölzel Cornelia Netherlands 6 135 0.5× 223 1.2× 119 0.7× 7 0.1× 12 0.5× 6 381
Jason S. White United States 8 30 0.1× 209 1.1× 307 1.8× 26 0.5× 17 0.7× 10 444
Joshua S. Hardin United States 7 45 0.2× 123 0.7× 175 1.0× 140 2.7× 20 0.9× 19 437

Countries citing papers authored by Mingxia Song

Since Specialization
Citations

This map shows the geographic impact of Mingxia Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Song more than expected).

Fields of papers citing papers by Mingxia Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxia Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Song. The network helps show where Mingxia Song may publish in the future.

Co-authorship network of co-authors of Mingxia Song

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxia Song. A scholar is included among the top collaborators of Mingxia Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxia Song. Mingxia Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zaremba, Anne, Friedegund Meier, Christian Schlein, et al.. (2022). Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants. Pigment Cell & Melanoma Research. 35(6). 573–586. 1 indexed citations
2.
Espinosa, Jaclyn R., Steven E. Bosinger, Alton B. Farris, et al.. (2014). CD57+CD4 T Cells and Belatacept Resistant Rejection.. Transplantation. 98. 141–141. 1 indexed citations
3.
Griewank, Klaus, Rajmohan Murali, Bastian Schilling, et al.. (2013). TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. British Journal of Cancer. 109(2). 497–501. 91 indexed citations
4.
Osen, Wolfram, Sabine Soltek, Mingxia Song, et al.. (2010). Screening of Human Tumor Antigens for CD4+ T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries. PLoS ONE. 5(11). e14137–e14137. 16 indexed citations
5.
Sun, Yuansheng, Mingxia Song, Elke Jäger, et al.. (2008). Human CD4+ T Lymphocytes Recognize a Vascular Endothelial Growth Factor Receptor-2–Derived Epitope in Association with HLA-DR. Clinical Cancer Research. 14(13). 4306–4315. 6 indexed citations
6.
Zeng, Jinyang, Jan Müller‐Berghaus, Xuan Duc Nguyen, et al.. (2006). Identification of HLA class I dependent immunogenic peptides from clonotypic TCRβ expressed in cutaneous T‐cell lymphoma. International Journal of Cancer. 119(10). 2476–2480. 4 indexed citations
7.
Paschen, Annette, Mingxia Song, J Janda, et al.. (2006). Identification of a cross-reactive HLA-DRB1*0301-restricted CD4 T cell response directed against cholesterol-binding cytolysins from two different pathogens. Microbes and Infection. 8(8). 2034–2043. 3 indexed citations
8.
Paschen, Annette, Weiqing Jing, Ingo Drexler, et al.. (2005). Melanoma patients respond to a new HLA‐A*01‐presented antigenic ligand derived from a multi‐epitope region of melanoma antigen TRP‐2. International Journal of Cancer. 116(6). 944–948. 7 indexed citations
9.
Sun, Yuansheng, Stefan Stevanović, Mingxia Song, et al.. (2005). The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes. Blood. 107(4). 1476–1483. 9 indexed citations
10.
Paschen, Annette, Mingxia Song, Wolfram Osen, et al.. (2005). Detection of Spontaneous CD4+ T-Cell Responses in Melanoma Patients against a Tyrosinase-Related Protein-2–Derived Epitope Identified in HLA-DRB1*0301 Transgenic Mice. Clinical Cancer Research. 11(14). 5241–5247. 15 indexed citations
11.
Scheibenbogen, Carmen, Yuansheng Sun, Ulrich Keilholz, et al.. (2002). Identification of known and novel immunogenic T‐cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL‐2‐based treatment. International Journal of Cancer. 98(3). 409–414. 26 indexed citations
12.
Paschen, Annette, Rosa Méndez, Pilar Jiménez, et al.. (2002). Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events. International Journal of Cancer. 103(6). 759–767. 81 indexed citations
13.
Sun, Yuansheng, Alice J.A.M. Sijts, Mingxia Song, et al.. (2002). Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.. PubMed. 62(10). 2875–82. 79 indexed citations
14.
Sun, Yuansheng, Mingxia Song, Markus Maeurer, & Dirk Schadendorf. (2001). Segregation of Effector Mechanisms in a Tumour‐Specific CD8+ T‐Cell Clone Correlates with CD30 Expression. Scandinavian Journal of Immunology. 54(3). 314–320. 5 indexed citations
15.
Sun, Yuansheng, Mingxia Song, Stefan Stevanović, et al.. (2000). Identification of a new HLA-A*0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. International Journal of Cancer. 87(3). 399–404. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026